Android
Zerodha Broker (Free Delivery)

India's No. 1 Broker with Best Software Trade @ Flat Rs 20

Open Instant Account
market update arrow Coronavirus LIVE updates: India cases at 6,312,584; nearly 5.3 mn cured arrow Manufacturing activity expands at fastest pace in 8 years in September: PMI arrow Latest news LIVE updates: Section 144 imposed in UP's Hathras district arrow Bajaj Auto rallies 8% on better-than-expected September sales arrow Expect no gains for Nifty over next year as stocks get expensive: Citi arrow Computer Age Management Services lists at 23% premium over issue price arrow MARKET LIVE: Sensex zooms 500 points; Chemcon lists at 115% premium arrow MARKET LIVE: Sensex zooms 500 points; Chemcon lists at 115% premium arrow Chemcon Speciality makes strong debut, lists at 115% premium to issue price arrow Google's Nest Audio smart speaker coming to India soon: What's new and more arrow Inox Leisure, PVR surge up to 17% on reopening of cinemas from October 15 arrow We are converting crisis into opportunity, says FM Nirmala Sitharaman arrow What makes 'Namaste' the perfect greeting in the times of Covid-19 pandemic arrow Short-cut to save lives: How pharma is changing to develop Covid-19 vaccine arrow Recovery patchy; stimulus at appropriate time: FM Nirmala Sitharaman arrow General Atlantic to invest Rs 3,675 cr into Reliance Retail for 0.84% stake arrow Centre keeps borrowing programme unaltered at Rs 4.34 trillion in H2 arrow GST collections for Sept may cross Rs 95,000 cr for first time in FY21 arrow Retail credit growth moderates after seeing a jump in July, shows data arrow Core sector output shrinks for sixth straight month in August, down 8.5% arrow India posts current account surplus of $19.8 bn as trade deficit narrows arrow From low prices to weak competition, how Titan hit gold during pandemic arrow Gold set for worst monthly fall in 4 years as dollar strengthens arrow Brookfield India Real Estate Trust files draft document with Sebi arrow After LVB, Dhanlaxmi Bank shareholders oust chief executive Sunil Gurbaxani

JUBILANT LIFE SCIENCES LIMITED 733.80 2.85 (0.39%)

  • BSE: 520057
  • |
  • NSE: JUBILANT
  • |
  • ISIN NO: INE700A01033
  • |
  • INDUSTRY: Pharmaceuticals
Profile

JUBILANT

JUBILANT

In 1978, Jubilant Life Sciences or formerly known as Jubilant Organosys was being incorporated. Also, it has about three subsidiary companies in India, such as Jubilant Chemsys for medicinal chemistry services, Jubilant Biosys for bio/chemo informatics databases and drug discovery services and Clinsys Clinical Research for clinical research. It sells its products worldwide in more than 50 countries, and its subsidiaries are located in the USA, China, and Be ... lgium, such as Jubilant Pharmaceuticals Inc for the generic pharmaceutical and Clinsys Clinical Research Inc for the clinical research. It also operates marketing subsidiaries in both China and the USA. Further, it also has four manufacturing locations in India located at Gajraula (in Uttar Pradesh), Nanjangud (in Karnataka), Nira (in Maharashtra) and Samlaya (in Gujarat) and a US FDA approved manufacturing facility for the dosage forms are located in Maryland, USA.

The business of the company:

It offers drug discovery and development services, custom research and manufacturing services, fine chemicals, advanced intermediates, active pharmaceutical ingredients, regulatory affairs services, and dosage forms. Also, it is an integrated pharmaceutical & life sciences company. It is the most extensive Custom Research and Manufacturing Services (or CRAMS) player and a leading Drug Discovery and Development Solution (or DDDS) provider overseas. It also offers Life Science Products and Services over the value chain, and serve its customers on a global basis with its ground presence in India, Europe, North America, and China. It is also well recognized as a Partner of Choice by leading life sciences companies globally.

Several Business Divisions:

Life Science Products:

Life Science Ingredients, which includes Advance Intermediates, Active Pharmaceutical Ingredients (or APIs), Exclusive Synthesis - Intermediates & APIs, Fine Chemicals, Nutrition Ingredients, Life Sciences Chemicals, and Crop Science Chemicals.
  1. Active Pharmaceutical Ingredients:It offers a spectrum of pharmaceutical bulk actives and intermediate in therapeutic sectors of the Central nervous system, Gastrointestinal, cardiovascular system, and Anti-infectives.
  • Patent non-infringing technologies
  • State-of-the-art pilot as well as multipurpose commercial-scale.
  • Several Pharmaceutical manufacturing plants conforming to cGMP guidelines and approved by many regulatory authorities such as French AFSSAPS, US FDA, and Japanese PMDA.
  • Also, the R & D facilities support the early development of generic APIs.
  • High-quality documents such as Drug Master Files.
It has 45+ products under several stages of development. Also, the new product development is primarily focused on therapeutic categories of Cardiovascular system, Central Nervous Systems, and Antidiabetics. Also, the dedicated team of more than 100 research scientists works in our state-of-the-art research centers located at Noida and Nanjangud. Such research facilities are being equipped with the latest and innovative scientific instruments.
  1. Advance Intermediates:It manufactures and markets Pyridine as well as its derivatives. They are also used as advance intermediates by the pharmaceutical and agrochemical industries and several other industries. Also, Pyridine has specific chemical properties such as receptiveness to chemical ions, which make it useful in a spectrum of chemical reactions.
  2. Fine Chemicals:It offers a spectrum of Fine Chemicals that are mostly used as building blocks and intermediates are mainly in pharmaceutical and agrochemical bulk actives. Presently, it provides 165+ 165 Fine chemicals to its customers on a global basis. Such fine chemicals are being used in Active Pharmaceutical Ingredients for a spectrum of therapeutic sections that include anti-ulcer, anti-AIDS, anti-tuberculosis, anti-arthritics, anti-infective, and more. Also, in the agrochemical industry, such fine chemicals are mainly used for manufacturing insecticides, herbicides, and fungicides. They are mostly used in personal care products.
  3. Exclusive Synthesis - Intermediates & APIs: The Jubilant Life Sciences’ Exclusive Synthesis business is like an outsourcing partner for several Life Science innovators as well as it has adopted the 'Active Selection' concept for the spectrum of services that it offers to its customers.
  • Custom Manufacturing Intermediates & APIs: The company focuses on the manufacturing of both Commercial and Clinical phase products from grams to kilos and 100’s of tons.
  • cGMP Pilot Plants:
It has a state-of-art Kilo-Lab, and Pilot plants and both are located at Gajraula (in Near Delhi) for Non-Regulatory steps synthesis and other located at Nanjangud (near Bengaluru) for Regulatory steps.
  • Also, the reactors ranging from 20L to 630L (it includes Glass assemblies and Cryogenic reactors, and autoclaves that operate at 58 Kg/cm2 and 280oC).
  • The operations at both very high (at 450oC) and very low (at –80oC) temperatures.
  • Commercial Plants: It operates several large commercial plants located at Gajraula (near Delhi) for Non-Regulatory steps and other at Nanjangud (near Bengaluru) for the cGMP intermediates and APIs. Also, the Nanjangud facility is USFDA approved.
  • The Nanjangud has 107 reactors (that includes Cryogenic and Hastelloy) and range from 1 KL to 12 KL, along with a reactor volume of about 650 KL with Autoclaves that operate at 58 kg/cm2 & 280oC, with Fluorination and Bromination facilities.
  • Also, Gajraula has about 100 reactors (it includes SS, MSGLR, Hastelloy, and Cryogenic) and its ranges from (1KL to 12 KL), along with a reactor volume of about 600 KL, with Autoclaves operated at 58 Kg/cm2 & 280oC, Bromination and Fluorination facilities.
  • Highly Efficient Distillation Columns, High Vacuum System, along with the structured packing of 30 meters packed height, Solvent Recovery Plants. Also, DCS process control systems are being used extensively.
  1. Nutrition Ingredients:It is a significant player in the Nutrition market; and the company also manufactures and markets a spectrum of nutritional ingredients and formulations for the application over the food, feed, pharmaceutical, and personal care. It enjoys a robust position of both trust and reliability, along with its customers across the world on account of its quality of services and products. Also, many international regulatory authorities certified its manufacturing facilities, and its products conform to the significant international pharmacopeias. It also offers:
  • Vitamins: B3, B4
  • Premixes
  • Enzymes
  • Specialty & some other components
  1. Crop Science Chemical: The Company's CSC (or Crop Science Chemicals) business offers the Key advance intermediates as well as Actives for Crop Science and Agrochemical industry.
Also, along with Jubilant's aim on the integrated offering of products to all its clients, it has extended its expertise in several areas of Pyridines & its derivatives for developing the best in class products for the Crop Science and Agrochemicals industry. And as a global leader in Pyridine & its derivatives, it aims at launching new products and accomplishing the global scale of operations for most of the associated Crop Science products specifically for the Agrochemicals industry.
  1. Life Sciences Chemicals: It is a leading manufacturer of Acetyls in India for more than 20 years. It also enjoys a global position in such products. The Company also uses renewable biomass (such as molasses; which is a by-product from the sugar mills), as feedstock for manufacturing the Acetyls. Thus, it is not impacted by the cost cycles that affect the industry globally.
  2. Jubilant Life Sciences:It owns distilleries located in Gajraula and Nira. Such types of strategies to the business are located in the 2 most extensive sugar belts of India (Uttar Pradesh and Maharashtra). It has a long-term contract, along with the sugar mills to meet alcohol needs while offering easy access to feedstock.
Product List: Acetic AcidAcetic AnhydrideEthyl AcetateMonochloroacetic Acid Generics include Solid Dosage Forms, Radiopharmaceuticals, and Allergenic Extracts.

Life Science Services:

  1. CMO of sterile & non-sterile products:It operates in North America, along with two facilities that are specialized in the manufacture of sterile and non-sterile products. One of them is in Spokane, Washington, the USA, and some others are located in Montreal, Canada, and offers both sterile and non-sterile manufacturing services. Also, the Jubilant HollisterStier Contract Manufacturing is recognized worldwide for its execution, quality, manufacturing capabilities, and robust regulatory track records.
  2. Drug Discovery & Development Services: Both drug discovery and development at the company is being driven by the passion for offering affordable drugs to patients globally in the areas of unmet needs. Also, its scientists collaborate via technology and therapeutic platforms for identifying and validating novel small molecules and platforms that will help in enabling the first or best in class healthcare efforts of our collaborators. Also, High-quality innovation is being supported by a robust and highly efficient R&D process, which makes the company as a preferred partner for several global pharmaceuticals as well as biotech companies.
  3. Healthcare:It is the company's First Trust Healthcare, which is a subsidiary of Jubilant Life Sciences, which is located in Kolkata, and it is driving the healthcare initiative of Jubilant in India. Also, it holds several global leadership positions, such as:
  • 1 in Pyridine and its derivatives
  • 1 in Lutidines and Collidines
  • 1 in API of Carbamazepine, Oxcarbazepine, Lamotrigine, Pinavarium Bromide, and ValSartan.
  • 2 in API of Risperidone and Citalopram.
  • 3 in Niacinamide & Niacin, Allergenic Extracts are leading the North American vaccine and immunotherapy company.
  • It is also among several market leaders in CMO - sterile injectables in North America.
  • It is also among the top 3 in different Generic Dosage Forms.

Some Milestones of the Company:

  • 2011-12:
  • The Best CFO in the pharmaceutical and healthcare space in the year 2011 for Jubilant’s Group CFO, Mr. R. Sankaraiah.
  • It received the International Quality & Productivity Centre Award (in 2011) for the Best Innovative Continuous Improvement Project - Process Reengineering being implemented in North American Subsidiaries.
  • 2012-13:
  • It received the NDTV Profit Business Leadership Award in 2012 for Corporate Social Responsibility.
  • It received the National Quality Excellence Award for best in Class manufacturing given by Stars of the Industry Group.
  • Also, the CII “National Award for Excellence in Water Management 2012 “as “Water Efficient Unit” for the Gajraula Unit.
  • It received the Manufacturing Excellence Gold Award - Process Sector for 2012.
  • It won the I.C.C. Award for Water Resource Management in the Chemical Industry in 2011.
  • It won the Golden Peacock Award for Sustainability 2012.
  • It won the Golden Peacock Environment Management Award in 2012.

Read More
Key Data
  • Market cap 11584.00 CR.
  • Book value 163.67
  • Stock P/E 34
  • Dividend Yield 0.69%
  • ROCE 10.17%
  • ROE 13.18%
  • Sales Growth (3Y) 8.02%
  • Face Value (3Y) 1.00
Trend Analysis
  • Short Term Trend :
    Down
  • Medium Term Trend :
    Down
  • Long Term Trend :
    Not Clear

Are you friends with trend?

There is a saying in stock market, "Trend is your best friend"

It means, a good trader doesn't place his money against the trend. Many new traders lose money because they are trying to catch trend reversals but seasoned traders wait for a clear trend to emerge before taking the trade in the direction of trend.

Day Technicals

What is Opening Range Breakout?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

NR7

What is NR7 trading strategy?

Narrow Range trading strategy or NR7 Trading strategy is a breakout based method which assumes that the price of security trends up or down after a brief consolidation in a narrow range.

Opening Price clues

How to use Opening Price Clues in your trades?

If the stock has same open and high after it has traded for some time, it implies there was a consistent selling pressure that didn't allow the stock to move higher from the opening price. Similarly, if the stock has same open and low price, it implies there was a consistent buying intent that kept the stock price above the opening price.

Day High Low Range
TIME LOWEST HIGHEST
10 AM 733.55 741.90
11 AM 732.90 741.90
12 PM - -
1 PM - -
2 PM - -
3 PM - -
Japanese Candlestick Patterns
Candle Pattern 1 :None
Candle Pattern 2 : None
Candle Pattern 3 :None
Candlestick Price Action
Higher High Higher Low
Pivot Points
Name S4 S3 S2 S1 Pivot Points R1 R2 R3 R4
classic 669.98 690.08 710.18 720.57 730.28 740.67 750.38 770.48 790.58
woodie's 669.64 689.74 704.82 709.85 724.92 729.95 745.02 750.05 770.15
fibonacci - 710.18 717.86 722.61 730.28 737.96 742.71 750.38 -
camarilla 719.90 725.42 727.26 729.11 -- 732.79 734.64 736.48 742.00
Past Performance & Moving Averages
Day’s LOW HIGH RANGE SMA PERFORMANCE Nifty
10 DAY 694.15
824.00
744.88 -4.20 % 0.26 %
20 DAY 686.00
840.00
757.89 0.97 % -1.51 %
50 DAY 686.00
909.00
788.48 -9.65 % 0.04 %
100 DAY 426.40
909.00
693.09 12.80 % 9.18 %
200 DAY 234.35
909.00
577.34 124.91 % 22.72 %
YTD 234.35
909.00
579.88 37.76 % -7.54 %
52 Week 234.35
909.00
548.52 49.16 % -0.09 %

Why are moving Averages important in technical Analysis?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

Gaps On Day Chart
Unfilled Gap Up On 2020-06-05
545.00 ~ 537.35 SUPPORT
Unfilled Gap Up On 2020-06-03
511.80 ~ 487.45 SUPPORT
Unfilled Gap Up On 2020-06-02
487.45 ~ 464.25 SUPPORT
Unfilled Gap Up On 2020-06-01
464.25 ~ 451.00 SUPPORT
Unfilled Gap Up On 2020-05-13
428.55 ~ 416.90 SUPPORT
Unfilled Gap Up On 2020-04-22
352.60 ~ 352.10 SUPPORT
Unfilled Gap Up On 2020-04-08
303.30 ~ 295.60 SUPPORT
Unfilled Gap Down On 2018-02-23
970.00 ~ 970.15 RESISTANCE
Industry Growth Rate

In Last 1 Year the industry has grown by 11.54 %

In Last 5 Year the industry has grown by 12.06 %

Peer comparison

Sales

COMPANY NAME 2014 2015 2016 2017 2018 2019
JUBILANT 5762.00 5751.00 5749.00 5861.00 7518.00 9111.00
SUNPHARMA 16080.00 27392.00 28487.00 31578.00 26489.00 29066.00
LUPIN 11286.00 12770.00 14256.00 17367.00 15797.00 16718.00
CIPLA 10173.00 11345.00 13790.00 14394.00 15156.00 16362.00
AUROPHARMA 8089.00 12103.00 13772.00 14910.00 16463.00 19564.00
Total 10278.00 13872.20 15210.80 16822.00 16284.60 18164.20

Financial

LAST FISCAL CURRENT GROWTH 10 YEAR CAGR
S.NO. COMPANY NAME MARKET CAP CMP BOOK VALUE EPS STOCK P/E ROE ICR REVENUE NET PROFIT NPM REVENUE NET PROFIT REVENUE NET PROFIT
1 SUN PHARMACEUTICAL INDUSTRIES LTD. 120101.21 500.50 98.33 11.11 38.37 11.10 11.45% 29066.00 2665.00 9.17% 9.73% 27.15% 21.39% 3.90%
2 MARKSANS PHARMA LTD. 92969.02 22.65 11.85 1.87 10.83 1.85 13.20% 1000.00 76.00 7.60% 9.53% 130.30% 10.88%
3 MOREPEN LABORATORIES LTD. 71575.87 15.90 6.43 0.64 23.05 0.32 34.00% 769.00 29.00 3.77% 26.69% 15.56%
4 NEULAND LABORATORIES LTD. 50071.35 390.75 542.16 12.74 36.68 1.23 3.63% 667.00 16.00 2.40% 26.57% 33.33% 8.07% 2.92%
5 GUFIC BIOSCIENCES LTD. 41419.69 53.30 10.85
6 DIVI'S LABORATORIES LTD. 80863.99 3047.40 266.77 50.96 38.52 25.53 374.60% 4946.00 1353.00 27.36% 27.11% 54.28% 15.41% 12.49%
7 DR.REDDY'S LABORATORIES LTD. 86176.55 5187.05 852.69 117.47 26.67 23.49 35.71% 15448.00 1950.00 12.62% 8.17% 105.91% 8.45%
8 RPG LIFE SCIENCES LTD. 41788.21 252.45 105.02
9 SMS PHARMACEUTICALS LTD. 34236.68 40.25 42.07 4.73 8.97 5.00 7.50% 465.00 40.00 8.60% 0.43% 25.00%
10 CIPLA LTD. 62442.20 774.75 209.71 18.96 23.60 9.49 18.43% 16362.00 1528.00 9.34% 7.96% 8.29% 12.67% 7.08%
11 TORRENT PHARMACEUTICALS LTD. 47433.73 2801.75 323.66 25.78 77.62 5.13 3.86% 7673.00 436.00 5.68% 28.96% 16.89% 9.01%
12 PIRAMAL ENTERPRISES LTD. 28237.95 1251.95 823.58 70.51 20.69 39.81 1.61% 13215.00 1473.00 11.15% 24.31% 15.08% 16.64%
13 LUPIN LTD. 45611.17 1006.60 384.76 13.40 53.92 6.74 9.28% 16718.00 607.00 3.63% 5.83% 141.83% 16.04% 1.92%
14 NECTAR LIFESCIENCES LTD. 29495.44 13.16 49.89 2.12 6.56 2.18 1.78% 2779.00 48.00 1.73% 48.29% 14.38%
15 AUROBINDO PHARMA LTD. 46652.85 796.60 206.07 40.36 12.59 40.08 15.03% 19564.00 2365.00 12.09% 18.84% 20.53% 37.21%
16 Alkem Laboratories Ltd 33362.57 2779.05 501.34 63.61 37.53 31.71 20.36% 7357.00 761.00 10.34% 14.94% 20.60%
17 ABBOTT INDIA LTD. 35207.59 16512.20 1004.00
18 CADILA HEALTHCARE LTD. 40443.63 394.90 90.85 18.05 15.05 18.13 15.32% 13166.00 1849.00 14.04% 10.59% 4.11% 16.49% 19.83%
19 GLAXOSMITHKLINE PHARMACEUTICALS LTD. 26545.92 1567.35 138.61 26.29 52.38 2.63 581.00% 3128.00 445.00 14.23% 8.95% 26.78%
20 KILITCH DRUGS (INDIA) LTD. 13893.00 89.90 98.74 2.49 51.55 0.25 11.22% 82.40 3.83 4.65% 61.70%
Sales

What is Sales Trend ?

Sales trend is a methodology to understand sales results which helps in understanding the trends of the market over a specific period of time. Sales results are an indicative of the sales patterns followed by the customer over a time period.

Profitability

What is Profit & EPS Trend ?

EPS Trends was initially built in late 2015 when I was just getting into frontend development. Coming from a background in Rails, I was frustrated with how many decisions you had to make early on as a javascript developer.

Net Profit
EPS

What is EBITDA Margin & EBIT Margin ?

Corporate accounting is required to adhere to the standards and practices collectively referred to as the generally accepted accounting principles. EBITDA is an excellent way for corporate accountants to start compiling data, but it should not be considered an absolute result. This is due to the fact that many consider EBITDA more of a broad stroke than a definitive form of accounting practice.

EBITDA Margin
EBIT Margin
NPM
Cash Flow

Why is the Cash Flow Analysis important?

A business needs cash to pay its expenses, to pay bank loans, to pay taxes and to purchase new assets. A cash flow report determines whether a business has enough cash to do exactly this.

Operating Activities
Financing Activities
Investing Activities
Financial Health

What Is Financial Health?

Financial health is a term used to describe the state of one's personal monetary affairs. There are many dimensions to financial health, including the amount of savings you have, how much you’re putting away for retirement, and how much of your income you are spending on fixed or non-discretionary expenses.

Debt to Equity
Piotroski Score
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

What Is the Piotroski Score?

The Piotroski score is a discrete score between 0-9 that reflects nine criteria used to determine the strength of a firm's financial position.

Altman Z Score (Mfg Company)
  • Distress (< 1.81)
  • Caution (>1.81 < 2.99)
  • 4.00
    Safe (3 & above)
Altman Z Score (Non-Mfg Company)
  • Distress ( < 1.23)
  • Caution (>1.23 < 2.6)
  • 6.81
    Safe (2.6 & above)
Valuation

What Is Valuation?

Valuation is the analytical process of determining the current (or projected) worth of an asset or a company. There are many techniques used for doing a valuation. An analyst placing a value on a company looks at the business's management, the composition of its capital structure, the prospect of future earnings, and the market value of its assets, among other metrics.

What is the significance of Rollover data?

Rollover in an important data point and should be analyzed in the expiry week. Rollover involves carry forwarding of ‘futures’ positions from one series (which is nearing expiry date) to the next one.

Rollover percentage actually indicates whether the traders are willing to carry forward their existing. positions (long or short) to the next series or not. Generally, the rollover figures alone will not indicate which direction traders are betting on. You should also check whether absolute open interest is increasing or decreasing over expiries

What is Options Max Pain Theory?

Options Max Pain Theory suggests,

“On option expiration day, the underlying stock price often moves toward a point that brings maximum loss to option buyers.”

Ratio Analysis

The Bank was incorporated in the year 2004 by Rana Kapoor and Late Ashok Kapur, which is a new age private sector bank. And since the inception of the bank has fructified into a “Full-Service Commercial Bank,” it has steadily built Corporate and Institutional Banking, Financial Markets, Investment Banking, Corporate Finance, Branch Banking, Business and Transaction Banking, and Wealth Management business lines across the whole country.

It is well-equipped to offer a spectrum of products and services to all the corporate and retail customers.

Read More
Bulk Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
JUBILANT 2020-03-05 MORGAN STANLEY ASIA (SINGAPORE) PTE. S 1626012.00 495.75
JUBILANT 2020-03-05 EAST BRIDGE CAPITAL MASTER FUND LIMITED P 2405583.00 497.60
JUBILANT 2019-11-18 JUBILANT STOCK HOLDING PRIVATE LTD S 1160000.00 493.00
JUBILANT 2019-06-20 RANCE INVESTMENT HOLDINGS LIMITED S 975000.00 470.00
JUBILANT 2019-06-20 MILLER HOLDINGS PTE LTD P 975000.00 470.00
JUBILANT 2019-06-10 RANCE INVESTMENT HOLDINGS LIMITED S 975000.00 475.55
JUBILANT 2019-06-10 MILLER HOLDINGS PTE LTD P 975000.00 475.55
JUBILANT 2016-04-26 DEUTSCHE SECURITIES MAURITIUS LIMITED S 3103408.00 394.50
JUBILANT 2016-04-26 CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED P 3142946.00 394.50
JUBILANT 2013-09-02 DILIGENT SERVICES P LTD S 3297347.00 72.95
JUBILANT 2013-09-02 JUBILANT STOCK HOLDING PRIVATE LIMITED P 3300000.00 72.95
JUBILANT 2013-08-14 JUBILANT STOCK HOLDING PRIVATE LIMITED P 2935000.00 89.17
JUBILANT 2013-08-14 DILIGENT SERVICES P LTD S 2920000.00 89.16
JUBILANT 2010-07-02 HPC (MAURITIUS) LIMITED S 2556483.00 347.73
JUBILANT 2009-04-22 DEUTSCHE SECURITIES MAURITIUS LIMITED P 903582.00 120.00
JUBILANT 2009-03-27 COPTHALL MAURITIUS INVESTMENT LIMITED S 900000.00 94.00
JUBILANT 2005-07-27 KOTAK MAHINDRA CAPITAL CO P 1329690.00 969.98
JUBILANT 2005-07-27 GOLDMAN SACHS INVESTMENT S 1328250.00 970.00
JUBILANT 2005-07-07 DILIGENT SERVICES P LTD S 611400.00 970.00
JUBILANT 2005-07-07 GYAN TRADERS LTD S 64823.00 970.00
JUBILANT 2005-07-07 MONET SECURITIES P LTD S 20456.00 970.00
JUBILANT 2005-07-07 LILLY EXPORTERS P LTD S 58421.00 970.00
JUBILANT 2005-07-07 SPARK SECURITIES P LTD S 273009.00 970.00
JUBILANT 2005-07-07 ANITA BUBNA S 2770.00 970.00
JUBILANT 2005-07-07 GOLDMAN SACHS INVESTMENT P 1350000.00 969.99
JUBILANT 2005-07-07 INDI STOCK P LTD S 39739.00 970.00
JUBILANT 2005-07-07 M PRASAD AND CO LTD S 180314.00 970.00
JUBILANT 2005-07-07 SCINDIA INVESTMENTS LTD S 95880.00 970.00
JUBILANT 2005-02-14 SENTINEL FINANCIAL SER.P S 169000.00 805.78
JUBILANT 2005-02-14 GOODMAN AND CO. DYNAMIC I P 500000.00 806.00
JUBILANT 2005-02-14 DILIGENT SERVICES P LTD S 135000.00 806.03
JUBILANT 2004-11-22 JUBILANT SECURITIES P LTD S 209500.00 840.99
JUBILANT 2004-11-22 PIONEER INERTMEDIARIES BU P 550000.00 841.06
JUBILANT 2004-11-22 PIONEER INTERMEDIARIES BU S 550000.00 847.98
JUBILANT 2004-11-22 JUBILANT CAPITAL P LTD S 204100.00 841.00
JUBILANT 2004-11-22 UBS SECURITIES ASIA LIMIT P 530000.00 847.92
JUBILANT 2004-10-14 INDI STOCK P LTD S 61299.00 757.00
JUBILANT 2004-10-14 SLOANE ROBINSON INVESTMEN P 300000.00 757.00
JUBILANT 2004-10-14 LILLY EXPORTERS P LTD S 80513.00 757.00
JUBILANT 2004-10-14 GYAN TRADERS LTD S 100174.00 757.00
Block Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
JUBILANT 2019-11-18 SSB CONSULTANTS & MANAGEMENT SERVICES PRIVATE LIMITED P 580000.00 493.00
JUBILANT 2019-11-18 HSB CORPORATE CONSULTANTS PRIVATE LIMITED P 580000.00 493.00
JUBILANT 2019-11-18 JUBILANT STOCK HOLDING PRIVATE LTD S 580000.00 493.00
JUBILANT 2019-11-18 JUBILANT STOCK HOLDING PRIVATE LTD S 580000.00 493.00
JUBILANT 2019-08-19 MAV MANAGEMENT ADVISORS LLP S 310000.00 456.00
JUBILANT 2019-08-19 MILLER HOLDINGS PTE LTD P 310000.00 456.00
JUBILANT 2019-06-21 CUMIN INVESTMENTS LIMITED S 650000.00 480.00
JUBILANT 2019-06-21 MILLER HOLDINGS PTE LTD P 650000.00 480.00
JUBILANT 2019-06-20 RANCE INVESTMENT HOLDINGS LIMITED S 975000.00 470.00
JUBILANT 2019-06-20 MILLER HOLDINGS PTE LTD P 975000.00 470.00
JUBILANT 2019-06-10 MILLER HOLDINGS PTE LTD P 975000.00 475.55
JUBILANT 2019-06-10 RANCE INVESTMENT HOLDINGS LIMITED S 975000.00 475.55
JUBILANT 2019-05-30 CUMIN INVESTMENTS LIMITED S 650000.00 501.10
JUBILANT 2019-05-30 MILLER HOLDINGS PTE LTD P 650000.00 501.10
JUBILANT 2019-05-21 TORINO OVERSEAS LIMITED S 770445.00 566.55
JUBILANT 2019-05-21 MILLER HOLDINGS PTE LTD P 770445.00 566.55
JUBILANT 2019-03-22 MILLER HOLDINGS PTE LTD P 450000.00 757.50
JUBILANT 2019-03-22 RANCE INVESTMENT HOLDINGS LIMITED S 450000.00 757.50
JUBILANT 2019-03-15 MILLER HOLDINGS PTE LTD P 450000.00 866.00
JUBILANT 2019-03-15 CUMIN INVESTMENTS LIMITED S 450000.00 866.00
JUBILANT 2019-03-07 CUMIN INVESTMENTS LIMITED S 650000.00 765.85
JUBILANT 2019-03-07 JUBILANT STOCK HOLDING PRIVATE LIMITED P 650000.00 765.85
JUBILANT 2018-11-09 GHI HSP LTD S 347825.00 748.00
JUBILANT 2018-11-09 GHI LTP LTD S 1095841.00 748.00
JUBILANT 2018-11-09 GHI LTP LTD P 1095841.00 748.00
JUBILANT 2018-11-09 EMPLOYEES RETIREMENT PLAN OF DUKE UNIVERSITY P 212861.00 748.00
JUBILANT 2018-11-09 GHI ERP LTD P 418055.00 748.00
JUBILANT 2018-11-09 GHI ERP LTD P 347825.00 748.00
JUBILANT 2018-11-09 GHI ERP LTD S 212861.00 748.00
JUBILANT 2018-11-09 GHI JBD LTD S 418055.00 748.00
JUBILANT 2018-06-04 AL MEHWAR COMMERCIAL INVSTMENTS LLC WHITING P 192931.00 769.00
JUBILANT 2018-06-04 ABU DHABI INVESTMENT COUNCIL WHITING S 192931.00 769.00
JUBILANT 2016-04-26 CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED P 3103408.00 394.50
JUBILANT 2016-04-26 DEUTSCHE SECURITIES MAURITIUS LIMITED S 3103408.00 394.50
Dividend history
Ex Date Amount
2020-03-09 5.00
2019-09-12 4.50
2018-09-12 3.00
2017-08-16 3.00
2016-08-18 3.00
2015-08-20 3.00
2014-08-21 3.00
2013-08-14 3.00
2012-08-14 3.00
2011-08-10 2.00
2010-09-17 2.00
2009-06-29 1.50
2008-09-17 1.50
2007-09-17 1.25
2001-08-28 6.00
Bonus Data
Company Name Split Date From Value To Value
Split Data
Company Name Split Date From Value To Value